Current status in cancer cell reprogramming and its clinical implications Kenan IzgiHalit CanatanBanu Iskender Review – Cancer Research 12 September 2016 Pages: 371 - 383
HOXB8 promotes tumor metastasis and the epithelial–mesenchymal transition via ZEB2 targets in gastric cancer Wen-Jin DingMin ZhouChun-Ying Qu Original Article – Cancer Research 19 October 2016 Pages: 385 - 397
A specific mode of microsatellite instability is a crucial biomarker in adult T-cell leukaemia/lymphoma patients Kaname MiyashitaKei FujiiNaokuni Uike Original Article – Cancer Research Open access 25 October 2016 Pages: 399 - 408
Risk factors for intestinal metaplasia in a southeastern Chinese population: an analysis of 28,745 cases Jian-Xia JiangQing LiuShun-Fu Xu Original Article – Cancer Research 10 November 2016 Pages: 409 - 418
53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM–CHK2–P53 pathway Jing YaoAi HuangHong Ma Original Article – Cancer Research 12 November 2016 Pages: 419 - 431
Expression of PIWIL3 in primary and metastatic melanoma Thilo GambichlerChristina KohsikMichael Sand Original Article – Cancer Research 17 November 2016 Pages: 433 - 437
Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma Thomas M. AtkinsonJennifer L. HayRichard D. Carvajal Original Article – Cancer Research 05 December 2016 Pages: 439 - 445
BRAF V600E-dependent role of autophagy in uveal melanoma Yinu ZhaoWeibin WangThomas J. Fahey III Original Article – Cancer Research 07 December 2016 Pages: 447 - 455
Detection of vertebral metastases: a meta-analysis comparing MRI, CT, PET, BS and BS with SPECT Tao LiuShenghao WangHuilin Yang Review – Clinical Oncology 17 October 2016 Pages: 457 - 465
Therapeutic role of axillary lymph node dissection in patients with stage IV breast cancer: a population-based analysis San-Gang WuFeng-Yan LiZhen-Yu He Original Article – Clinical Oncology 03 November 2016 Pages: 467 - 474
Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99m with blue dye versus indocyanine green fluorescent dye Andrea PapadiaIgnacio ZapardielAlessandro Buda Original Article – Clinical Oncology 03 November 2016 Pages: 475 - 480
Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: preliminary results Zhongzhi JiaRicardo Paz-FumagalliWeiping Wang Original Article – Clinical Oncology 08 November 2016 Pages: 481 - 489
FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem? Andrea PapadiaMaria Luisa GasparriMichael D. Mueller Original Article – Clinical Oncology 11 November 2016 Pages: 491 - 497
Presence of sarcomatoid differentiation as a prognostic indicator for survival in surgically treated metastatic renal cell carcinoma Liangyou GuHongzhao LiXu Zhang Original Article – Clinical Oncology 14 November 2016 Pages: 499 - 508
Survival of de novo stage IV breast cancer patients over three decades Dieter HölzelRenate EckelJutta Engel Original Article – Clinical Oncology 16 November 2016 Pages: 509 - 519
Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients’ prognosis Theodoros TokasMargaritis AvgerisConstantinos A. Constantinides Original Article – Clinical Oncology 17 November 2016 Pages: 521 - 532
Improvement of overall survival in stage IV melanoma patients during 2011–2014: analysis of real-world data in 441 patients of the German Central Malignant Melanoma Registry (CMMR) Andrea ForschnerFelizitas EichnerThomas Kurt Eigentler Original Article – Clinical Oncology 22 November 2016 Pages: 533 - 540
A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO) Jalid SehouliOliver TomèGerald Gitsch Original Article – Clinical Oncology Open access 28 November 2016 Pages: 541 - 550
Plasma microRNA-103, microRNA-107, and microRNA-194 levels are not biomarkers for human diffuse gastric cancer Isao OzeShu ShimadaYasuhito Yuasa Letter to the Editor 01 December 2016 Pages: 551 - 554